Loading...
XNASXXII
Market cap2mUSD
Dec 24, Last price  
4.91USD
1D
1.37%
1Q
1,685.33%
Jan 2017
-69.99%
IPO
-74.84%
Name

22nd Century Group Inc

Chart & Performance

D1W1MN
XNAS:XXII chart
P/E
—
P/S
0.08
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
20.11%
Rev. gr., 5y
4.03%
Revenues
32m
-48.15%
000001,012,14118,7757,278,383528,9918,521,99812,279,97916,600,24426,426,34725,832,53028,111,00030,948,00062,111,00032,204,000
Net income
-141m
L+135.41%
-59,786-29,672-82,146-55,469-89,933-1,353,903-6,735,281-26,153,158-15,595,358-11,031,931-11,581,430-13,029,117-7,966,911-24,195,578-19,711,000-32,609,000-59,801,000-140,775,000
CFO
-55m
L+6.33%
-43,186-33,547-42,451-87,591-32,004-3,449,430-1,764,4453,855,834-6,582,730-7,321,811-9,887,580-12,068,383-17,844,266-14,587,364-15,621,000-22,839,000-51,714,000-54,987,000
Earnings
Mar 26, 2025

Profile

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
URL
https://www.xxiicentury.com/
IPO date
Oct 17, 2006
Employees
198
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
32,204
-48.15%
62,111
100.69%
30,948
10.09%
Cost of revenue
75,371
112,015
32,153
Unusual Expense (Income)
NOPBT
(43,167)
(49,904)
(1,205)
NOPBT Margin
Operating Taxes
47
(434)
14
Tax Rate
NOPAT
(43,214)
(49,470)
(1,219)
Net income
(140,775)
135.41%
(59,801)
83.39%
(32,609)
65.44%
Dividends
Dividend yield
Proceeds from repurchase of equity
27,899
34,851
37,737
BB yield
-11,575.19%
-314.13%
-125.09%
Debt
Debt current
6,853
1,589
904
Long-term debt
11,685
7,964
3,172
Deferred revenue
Other long-term liabilities
1,123
516
21
Net debt
16,480
(12,342)
(47,005)
Cash flow
Cash from operating activities
(54,987)
(51,714)
(22,839)
CAPEX
(5,617)
(4,429)
(1,071)
Cash from investing activities
16,816
22,578
(27,729)
Cash from financing activities
37,209
30,820
50,875
FCF
(20,770)
(69,637)
(6,053)
Balance
Cash
2,058
21,213
48,736
Long term investments
682
2,345
Excess cash
448
18,789
49,534
Stockholders' equity
(378,707)
(237,923)
(178,173)
Invested Capital
388,029
339,722
245,334
ROIC
ROCE
EV
Common stock shares outstanding
1,294
804
651
Price
0.19
-98.65%
13.81
-70.21%
46.35
40.45%
Market cap
241
-97.83%
11,094
-63.22%
30,168
58.06%
EV
16,721
(1,248)
(16,837)
EBITDA
(38,308)
(46,313)
331
EV/EBITDA
0.03
Interest
9,366
353
58
Interest/NOPBT